(Q39560084)

13 September 2017

1 reference

23 September 2020

Gastric cancer--the recognition of a chemosensitive tumour (English)

1 reference

antineoplastic combined chemotherapy protocols

13 September 2017

1 reference

23 September 2020

1 reference

23 September 2020

1 reference

23 September 2020

Cunningham D

1

1 reference

PMCID

2246874

13 September 2017

language of work or name

English

0 references

publication date

1 December 1988

5 references

British Journal of Cancer

13 September 2017

21 March 2019

3 April 2019

25 June 2019

23 September 2020

5 references

13 September 2017

21 March 2019

3 April 2019

25 June 2019

23 September 2020

58

1 reference

13 September 2017

695-699

1 reference

13 September 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1988.292

13 September 2017

0 references

cites work

5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246874

Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern Cooperative Oncology Group study (EST 3275).

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246874

Analysis of a prospectively randomized comparison of doxorubicin versus 5-fluorouracil, doxorubicin, and BCNU in advanced gastric cancer: implications for future studies

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246874

Programme for early detection of gastric cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246874

Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246874

A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246874

Evaluation of the prognostic factors in gastric cancer: the effect of chemotherapy on survival

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246874

Adenocarcinoma of the stomach: Review of 1,497 cases

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246874

Prognostic and therapeutic values of peritoneal cytology in gastric cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246874

Schedule-dependent antitumor effects of methotrexate and 5-fluorouracil

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246874

Use of 5-fluorodeoxyuridine (FUDR) as an adjuvant to the surgical management of carcinoma of the stomach.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246874

Results of treatment of stomach cancer. An appraisal of efforts for more extensive surgery and a rort of 1,983 cases.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246874

Chemotherapy in advanced gastric cancer

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246874

Advanced inoperable stomach cancer: a pilot study with the combination etoposide, adriamycin and cisplatin

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246874

Cancer of the stomach: a review of 854 patients

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246874

5-fluorouracil, adriamycin, and mitomycin-c (fam) combination chemotherapy in the treatment of advanced gastric cancer

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246874

Efficacy of prolonged intermittent therapy with combined 5-FU and methyl-CCNU following resection for gastric carcinoma. A veterans administration surgical oncology group report

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246874

Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, measurable adenocarcinoma of the lung and stomach.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246874

The use of triethylenethiophosphoramide as an adjuvant to the surgical treatment of gastric carcinoma

21 August 2018

1 reference

12 December 2020

Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer. The Gastrointestinal Tumor Study Group

1 reference

12 December 2020

Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy

1 reference

12 December 2020

Studies of Baker's antifol, methotrexate, and razoxane in advanced gastric cancer: A Gastrointestinal Tumor Study Group Report

1 reference

12 December 2020

Studies in prognostic factors relating to chemotherapy for advanced gastric cancer

1 reference

12 December 2020

Confirmed activity of FAM polychemotherapy in advanced gastric carcinoma

1 reference

12 December 2020

A phase II study of cisplatin in advanced gastric cancer

1 reference

12 December 2020

An interim report of a prospective, randomized, controlled study of adjuvant chemotherapy in operable gastric cancer: British stomach cancer group

1 reference

12 December 2020

Leukemia and Preleukemia after Adjuvant Treatment of Gastrointestinal Cancer with Semustine (Methyl-CCNU)

1 reference

12 December 2020

Cisplatin.An active drug in the treatment of disseminated gastric cancer

1 reference

12 December 2020

Advanced gastric cancer: Experience in Scotland using 5-fluorouracil, adriamycin and mitomycin-C

1 reference

12 December 2020

Cis-platinum as second-line chemotherapy in advanced gastric adenocarcinoma. A phase II study of the EORTC gastrointestinal tract cancer cooperative group

1 reference

12 December 2020

Programme for early detection of gastric cancer

1 reference

12 December 2020

An EORTC Gastrointestinal Group evaluation of the combination of sequential methotrexate and 5-fluorouracil, combined with adriamycin in advanced measurable gastric cancer

1 reference

12 December 2020

Phase II clinical trial of triazinate in combination with mitomycin C for patients with advanced gastric cancer

1 reference

12 December 2020

Phase II trial of cisplatin and etoposide in adenocarcinomas of the upper gastrointestinal tract

1 reference

12 December 2020

PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONIST

1 reference

12 December 2020

Carcinoma of the stomach

1 reference

12 December 2020

Sequential and combination chemotherapy of advanced gastric cancer

1 reference

12 December 2020

Improved combination chemotherapy in advanced gastric cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1988.292

1 reference

13 September 2017

1 reference

13 September 2017

1 reference

PMCID

2246874